End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.7 CNY | -0.34% | -2.59% | -1.98% |
May. 23 | Pacific Shuanglin Bio-pharmacy's Unit Gets Nod to Trial Intravenous Human Immunoglobulin | MT |
May. 09 | Pacific Shuanglin Bio-pharmacy Subsidiary Gets Plasmapheresis License | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.98% | 2.7B | |
-2.00% | 90.27B | |
-1.18% | 40.12B | |
-15.83% | 31.75B | |
+62.86% | 26.6B | |
-21.68% | 14.41B | |
-8.73% | 12.92B | |
-15.05% | 11.44B | |
-45.69% | 11.3B | |
+4.94% | 8.87B |
- Stock Market
- Equities
- 000403 Stock
- News Pacific Shuanglin Bio-pharmacy Co., LTD
- Pacific Shuanglin Bio-pharmacy Subsidiary Gets Plasmapheresis License